Delivery Order SPE2DB24D3013-SPE2DB25FFNYT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $5,013.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) with a ceiling value of $15,577.90. This firm fixed-price delivery order, with an ultimate completion date of April 22, 2025, represents a non-set-aside competitive award executed under DLA's broader pharmaceutical supply chain. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units) with a ceiling value of $8,348.51. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a contract value of $13,301.15. This firm fixed-price delivery order, which is not set-aside, is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's headquarters in...
- The Defense Logistics Agency awarded a $24,605.54 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed price contract type. This delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $4,552.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count packages). The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order. This award represents a...
- The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,532.48 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on August 29, 2025. This firm fixed-price, competitively awarded contract is scheduled for completion by September 2, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) valued at $3,199.76. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNYTDelivery Order
The Defense Logistics Agency awarded a $22,834.45 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Entresto 49 mg-51 mg tablets (180 count). This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award utilizing the company's existing indefinite delivery contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare systems. The parent contract enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare systems. The award reflects the company's established capability to meet federal medical procurement requirements and its role as a critical supplier within the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 8/4/25 |